IDiyas

For the Inventor, By the Inventor

Odenthal, Germany

Michael Schriewer

USPTO Granted Patents = 35

Average Co-Inventor Count = 4.6

ph-index = 11

Forward Citations = 406(Granted Patents)


Location History:

  • Leverkusen, DE (1987 - 1990)
  • Bayerwerk, DE (1991)
  • Odenthal, DE (1988 - 1998)

Company Filing History:

goldMedal35 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1987-1998

Loading Chart...
35 patents (USPTO):Explore Patents
1. 5723627 - Preparation of 7-(3-amino- and (1998-03-03),
2. 5648493 - Preparation of 7-(3-amino- and (1997-07-15),
3. 5607942 - 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid (1997-03-04),
4. 5457104 - Quinolone- and naphthyridonecarboxylic acid derivatives (1995-10-10),
5. 5453422 - Quinolone- and naphthyridone carboxylic acid derivatives, process for (1995-09-26),
6. 5416096 - 7-(1-pyrrolidinyl)-3-quinolone carboxylic acid derivatives as (1995-05-16),
7. 5284855 - 7-(2,7-diazabicyclo[3.3.0]octyl)-3-quinolone-and-naphthyridonecarboxylic (1994-02-08),
8. 5284842 - Quinolone- and naphthridone carboxylic acid derivatives, process for (1994-02-08),
9. 5252734 - Antibacterial 5-alkylquinolonecarboxylic acids (1993-10-12),
10. 5237060 - Process of preparing enantiomerically pure 1,8-bridged (1993-08-17),
11. 5202337 - 7-(2,7-diazabicyclo[3.3.0]octyl)-3-quinoline- and (1993-04-13),
12. 5190955 - Antibacterial (1993-03-02),
13. 5173484 - Quinolone- and naphthyridone carboxylic acid derivatives, process for (1992-12-22),
14. 5140033 - Antibacterial 5-alkylquinolonecarboxylic acids (1992-08-18),
15. 5061712 - Preparation of 7-(3-amino- and (1991-10-29),

Title: The Innovative Contributions of Michael Schriewer

Introduction

Michael Schriewer, an accomplished inventor based in Odenthal, Germany, has made significant strides in the field of antibacterial compounds. With a remarkable portfolio consisting of 35 patents, he has established himself as a key figure in pharmaceutical research and development.

Latest Patents

Among his latest innovations, Schriewer has focused on the preparation of antibacterial compounds. His patents describe intricate methods that involve condensing various oxo and amino compounds to create new, effective antibacterial agents. His expertise in synthesizing these compounds allows for advancements in medical treatments, demonstrating his commitment to improving health outcomes.

Career Highlights

Schriewer is affiliated with Bayer Aktiengesellschaft, a leading company known for its innovative pharmaceutical products. Throughout his career, he has successfully contributed to numerous projects focused on developing new therapies and improving existing pharmaceutical formulations. His extensive knowledge and skill have led to breakthroughs in the field of medicinal chemistry.

Collaborations

During his time at Bayer, Schriewer has collaborated with other esteemed professionals in the industry, including Klaus Grohe and Karl G Metzger. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality of his research and leading to the development of cutting-edge solutions in antibacterial treatments.

Conclusion

In conclusion, Michael Schriewer's contributions to the field of antibiotic research are noteworthy. His dedication to innovation and collaboration has resulted in numerous patents that continue to impact the medical community. With a strong foundation in science and a commitment to improving human health, Schriewer exemplifies the spirit of modern invention in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…